Skip to content

Cell Therapy in wound healing

The evaluation of tissue-engineered adipose-derived mesenchymal stem cells for wound healing in diabetes

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191007045008N1
Enrollment
32
Registered
2020-01-17
Start date
2019-10-12
Completion date
Unknown
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus type 1. Type 1 diabetes mellitus with ulcer

Interventions

Intervention 1: Intervention group: placenta scaffold containing stem cell. Intervention 2: Intervention group: placenta scaffold. Intervention 3: Intervention group: Adipose tissue derived stem cell

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Signature of informed consent Grade 1 or 2 wound on the Wagner Scale With diagnosis of diabetic or other chronic wound Female or male patient aged 15-45 Not pregnant

Exclusion criteria

Exclusion criteria: Patients with a history of uncontrolled disease Pregnancy Subjects with cancerous or pre-cancerous lesions in the area to be treated Patient with working activity who cannot be on sick-leave during the study period Known immunosuppressive disease, e.g. HIV infection, or hepatitis B or C infection

Design outcomes

Primary

MeasureTime frame
Ulcer Healing Rate. Timepoint: 7-14-21. Method of measurement: Ulcer Surface Area Measurement Using Instant Full-Scale Photography and analysis using Image J.

Secondary

MeasureTime frame
Time to ulcer healing. Timepoint: 7-14-21. Method of measurement: Instant full scale photography and analysis using Image J.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBabak Arjmand

Tehran University of Medical Sciences

barjmand@sina.tums.ac.ir+98 21 8835 4367

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026